An evolutionarily conserved ribosome-rescue pathway maintains epidermal homeostasis by Liakath-Ali, K et al.
  1
An evolutionarily conserved ribosome-rescue pathway maintains epidermal homeostasis  1 
 2 
Kifayathullah Liakath-Ali1, #, Eric W. Mills2, Inês Sequeira1, Beate M. Lichtenberger1, 3, Angela 3 
Oliveira Pisco1, Kalle H. Sipilä1, Ajay Mishra1,4, Harunori Yoshikawa5, Colin Chih-Chien Wu2, 4 
Tony Ly 5, 6, Angus I Lamond6, Ibrahim M. Adham7, Rachel Green2 and Fiona M. Watt1 5 
 6 
1. Centre for Stem Cells and Regenerative Medicine, King's College London, 28th floor, 7 
Guy's Tower Wing, London SE1 9RT, UK.  8 
2. Howard Hughes Medical Institute, Johns Hopkins School of Medicine, Department of 9 
Molecular Biology and Genetics, Baltimore, MD 21205, USA.  10 
3. Skin & Endothelium Research Division, Department of Dermatology, Medical University 11 
of Vienna, Lazarettgasse 14, 1090 Vienna, Austria 12 
4. Cambridge Infinitus Research Centre, University of Cambridge, Cambridge, UK 13 
5. Centre for Gene Regulation and Expression, School of Life Sciences, University of 14 
Dundee, Dow Street, Dundee, DD1 5EH, Scotland, UK. 15 
6. Wellcome Trust Centre for Cell Biology, University of Edinburgh, Michael Swann 16 
Building, King’s Buildings, Edinburgh EH9 3BF, Scotland, UK. 17 
7. Institute of Human Genetics, University Medical Centre of Göttingen, D-37073 18 
Göttingen, Germany. 19 
#   Present address: Department of Molecular and Cellular Physiology and Howard Hughes   20 
Medical Institute, Stanford University Medical School, 265 Campus Drive, CA 94305-21 
5453, USA 22 
 23 
Address for communication: fiona.watt@kcl.ac.uk 24 
 25 
 26 
 27 
 28 
  2
Ribosome-associated mRNA quality control mechanisms ensure fidelity of protein 29 
translation1,2. Although extensively studied in yeast, little is known about their role in 30 
mammalian tissues, despite emerging evidence that stem cell fate is controlled by 31 
translational mechanisms3,4. One evolutionarily conserved component of the quality control 32 
machinery, Dom34/Pelota (Pelo), rescues stalled ribosomes5. Here we show that Pelo is 33 
required for mammalian epidermal homeostasis. Conditional deletion of Pelo in those 34 
murine epidermal stem cells that express Lrig1 results in hyperproliferation and abnormal 35 
differentiation. In contrast, deletion in Lgr5+ stem cells has no effect and deletion in Lgr6+ 36 
stem cells has only a mild phenotype. Loss of Pelo results in accumulation of short 37 
ribosome footprints and global upregulation of translation rather than affecting expression 38 
of specific genes. Translational inhibition by rapamycin-mediated down regulation of 39 
mTOR rescues the epidermal phenotype. Our study reveals a novel role for the ribosome-40 
rescue machinery in mammalian tissue homeostasis and an unanticipated specificity in its 41 
impact on different stem cell populations.  42 
Pelo is expressed in mouse skin dermis and epidermis6 (Extended Data Fig. 1a). Dermal-specific 43 
deletion (PeloderKO) resulted in mice that were smaller than littermate controls but had a normal 44 
lifespan and no dermal abnormalities (Fig. 1a-f). Although Dom34 forms a functional complex 45 
with Hbs1 in yeast7 and the mammalian homolog Hbs1l is expressed in mouse skin6 (Extended 46 
Data Fig. 1b), the Hbs1l knockout (from exon 5; Extended Data Fig. 1c) had no epidermal 47 
defects (Extended Data Fig. 1d-f) and only small changes in dermal collagen deposition, 48 
thickness and cell density (Extended Data Fig. 1f-m). Another Pelo partner, Gtpbp28, does not 49 
have a reported skin phenotype.  50 
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Selective embryonic deletion of Pelo in Krt14 expressing epidermal cells, comprising the known 51 
stem cell subpopulations9, via Krt14Cre (PeloepiKO; Fig. 1g) phenocopied deletion via the 52 
ubiquitous Rosa26 locus10. Mice were born with scaly skin and an epidermal barrier defect 53 
(increased trans epidermal water loss; TEWL). They exhibited hair and weight loss, failing to 54 
thrive beyond 5 months (Fig. 1h-k). Epidermal thickening resulted from increased proliferation 55 
(Fig. 1l-q) and abnormal accumulation of differentiated cells (Fig. 1n-t). Wound closure was 56 
delayed (Fig. 1u), correlating with reduced proliferation, differentiation and migration (Extended 57 
Data Fig. 2a-i). Hyperproliferation in unwounded skin combined with delayed wound healing 58 
and abnormal differentiation has been observed in other mouse models11. There was also striking 59 
degeneration of the sebaceous glands and hair follicles, correlating with loss of the hair follicle 60 
bulge stem cell markers Krt15 and CD34 and the junctional zone stem cell marker Lrig1 61 
(Extended Data Fig. 3a-c).  62 
 63 
To determine whether the Pelo epidermal phenotype could be induced postnatally, we applied 4-64 
OHT to adult Pelofl/fl; Krt14CreERT (Extended Data Fig. 4a, b). Mice developed skin lesions, 65 
increased TEWL and delayed wound closure (Extended Data Fig. 4c-e). Degeneration of hair 66 
follicles and sebaceous glands correlated with keratinized cyst formation (Extended Data Fig. 4f, 67 
g). Sebocyte differentiation was disturbed, accompanied by expansion of Lrig1 labelling into the 68 
upper sebaceous gland (Extended Data Fig. 4h, i).  69 
 70 
PELO knockdown in cultured human epidermal keratinocytes led to an increase in stem cell 71 
colonies (Extended Data Fig. 5a-g). Immunostaining of epidermis reconstituted on decellularised 72 
dermis revealed increased proliferation of basal layer cells and increased differentiated layers 73 
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(Extended Data Fig. 5h-l). Therefore the mouse epidermal Pelo phenotype was recapitulated in 74 
human cells. 75 
 76 
To determine if there is a differential requirement for Pelo in different epidermal subpopulations, 77 
we conditionally deleted Pelo in Lgr5+, Lgr6+ and Lrig1+ stem cells (Fig. 2a-c). Pelo deletion in 78 
Lrig1+ cells recapitulated the effects of deleting Pelo in Krt14+ cells, whereas when Pelo was 79 
deleted in Lgr5+ and Lgr6+ cells differentiation was normal (Fig. 2d) with only a small increase 80 
in Ki67+ cells (Extended Data Fig. 5m, Fig. 2f). Pelo deletion in Lrig1+ cells increased cell 81 
proliferation in the upper hair follicle, with marked changes in follicles and sebaceous glands 82 
(Fig. 2e, Extended Data Fig. 6a, b). A significant increase in proliferation and TEWL occurred in 83 
the interfollicular epidermis (IFE) of Pelofl/fl; Lrig1CreERT2 mice compared to Pelofl/fl; Lgr5CreERT2 84 
and Pelofl/fl; Lgr6CreERT2 mice (Extended Data Fig.5m, Fig. 2f, h). There was a small increase in 85 
epidermal thickness in Pelofl/fl; Lgr6CreERT2 mice but TEWL was unaffected (Fig. 2g, h).  86 
 87 
We next generated Pelofl/fl; Lrig1CreERT2; Rosa26tdTom, Pelofl/fl; Lgr5CreERT2; Rosa26tdTom, and 88 
Pelofl/fl; Lgr6CreERT2; Rosa26tdTom mice, and treated with 4-OHT. Pelo deletion did not change the 89 
contribution of Lgr5 or Lgr6 progeny to the epidermis (Extended Data Fig. 6c, d). In contrast, on 90 
Pelo deletion Lrig1 lineage cells expanded downwards into the hair follicles and fully colonized 91 
the IFE (Extended Data Fig. 6c, d). In the presence or absence of Pelo, the Lrig1 lineage 92 
accounted for most Ki67+ epidermal cells; they also accounted for the increase in proliferative 93 
cells on Pelo deletion (Extended Data Fig. 6e, f).  94 
 95 
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Yeast cells lacking Dom34 (the homolog of Pelo) are enriched in short 16-18 nucleotide 96 
ribosome-protected fragments (RPFs) resulting from translation to the 3´end of truncated 97 
mRNAs5. Dom34/Rli1 mutant yeast accumulate full length 28-32 nucleotide RPFs in 3´ UTRs, 98 
consistent with the role of Dom34 and Rli1 in ribosome rescue and recycling on intact mRNAs, 99 
respectively12. In anucleate hematopoietic cells PELO and ABCE1 (Rli1) rescue non-translating 100 
3´UTR ribosomes13 and impact mRNA stability14. When we performed ribosomal profiling on 101 
keratinocytes from adult PeloepiKO mice by deep sequencing RPFs15., RPFs mapped primarily to 102 
the coding sequence (CDS) (Fig. 3a; Extended Data Fig. 7a, b), consistent with studies12 showing 103 
that loss of PELO alone does not substantially increase 3´ UTR ribosomes. CDS RPFs were 104 
primarily 28-34nts, the expected fragment size protected by mammalian ribosomes16, and 105 
displayed the three-nucleotide periodicity reflecting codon-by-codon movement of elongating 106 
ribosomes (Fig. 3b, gray bars). 107 
  108 
PeloepiKO profiles were enriched in 20-21 nucleotide RPFs (~4-5% of total RPFs compared to 109 
<1% in control cells) (Fig. 3a-c). Like the dominant population of 28-34nt RPFs, these footprints 110 
were primarily found in the CDS and showed a strong reading frame signal, indicating they too 111 
reflect the presence of elongating ribosomes, yet are shortened on their 3´ end after nuclease 112 
digestion (Fig. 3d, right). The density of short RPFs was evenly distributed and did not increase 113 
in frequency near the downstream 3´ portion of transcripts (Fig. 3a), as would be anticipated if 114 
they resulted from ribosomes encountering a directional RNA decay process17,18. Consistent with 115 
this, enrichment for 20-21 nt footprints was not linked to reduced transcript abundance in 116 
PeloepiKO cells (Fig. 3e; Supplementary Table 1). While Pelo is implicated in decay of the 117 
unusual histone mRNAs that lack polyA tails19, the short footprints did not demonstrate patterns 118 
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to indicate they result from ribosomes occupying transcripts that are being degraded. The 21mer 119 
RPFs seen in PeloepiKO cells could be the equivalent of the 16mer species in yeast5 and reflect the 120 
increased size of the mammalian ribosome20. However, we suggest they are equivalent to the 121 
21nt fragments observed21 in anisomycin-treated yeast cells and reflect dependence on Pelo-122 
associated quality control mechanisms in response to tRNA starvation in rapidly dividing cells. 123 
 124 
Epidermal Pelo loss led to significant changes in global translational efficiency (TE)15 (Fig. 3f, 125 
g; p < 0.01). TE values for keratins and ribosomal proteins were notably increased (Fig. 3f, g). 126 
There was significant enrichment for genes involved in RNA metabolism, protein synthesis, 127 
extracellular matrix and chromatin regulation (Fig. 3h; Extended Data Fig. 7c to e; 128 
Supplementary Table 2; Supplementary Table 3). There was also differential expression of 129 
canonical translational pathways, including upregulation of the mTOR (mechanistic target of 130 
rapamycin) pathway (Fig. 3h; Extended Data Fig. 8a, b). Since mTOR signaling leads to 131 
increased global translation22 (Extended Data Fig. 8c), we compared the Gtpbp2/tRNA mutant8 132 
and PeloepiKO gene expression datasets. We found significant overlap in translational signaling 133 
pathways (Extended Data Fig. 8d), suggesting that ribosome stalling is sensed by mTOR. 134 
 135 
The polysome-to-monosome ratio was increased in PeloepiKO cells (Fig. 3i), suggesting an overall 136 
increase in translation or accumulation of inactive stalled ribosomes. Krt86 transcripts were 137 
enriched in the heavy polysome fractions (Fig. 3j), consistent with the increases in TE values, 138 
suggesting increased overall translation. This was confirmed by quantifying global protein 139 
synthesis by O-propargyl-puromycin (OP-P) incorporation into newly synthesized polypeptide 140 
chains3,4. OP-P incorporation was increased in PeloepiKO IFE and hair follicles compared to 141 
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controls. Labelling was higher in the IFE suprabasal than basal layer, consistent with increased 142 
total protein synthesis during differentiation (Fig. 4a-d)23. The increase in OP-P labelling in total 143 
Pelo null keratinocytes (Fig. 4e) and stem cells (Integrin α6-high cells; Itga6high) was confirmed 144 
by flow cytometry (Extended Data Fig. 9a, Fig. 4f-j). Confocal microscopy revealed a striking 145 
increase in the size of PeloepiKO basal cells (Extended Data Fig. 9b-d), consistent with increased 146 
protein synthesis and a higher proportion of G2/M and S phase cells (Extended Data Fig. 9e).   147 
 148 
In control mice, Lrig1+ cells exhibited slightly higher protein synthesis than Lgr5 and Lgr6+ 149 
cells (Fig. 4k, l). When Pelo was deleted, protein synthesis in Lrig1+ cells was increased further 150 
relative to Lgr5 and Lgr6+ cells (Fig. 4k, l). RNA-seq (Extended Data Fig. 10a) revealed that 151 
regardless of whether or not Pelo was expressed, Lgr5+ cells clustered separately from Lrig1+ 152 
and Lgr6+ cells, while the gene expression profiles of individual populations did not cluster 153 
based on Pelo expression (Extended Data Fig. 10b-j, Supplementary Tables 4, 5). Therefore the 154 
Pelo epidermal phenotype primarily reflects increased translation, rather than expression of 155 
specific genes. 156 
  157 
To down regulate mTOR122, we applied rapamycin to adult PeloepiKO skin (Extended Data Fig. 158 
9f, g). There was a significant reduction in Ki67+ cells compared to controls (Extended Data Fig. 159 
9h-j). Phosphorylated ribosomal protein S6K (pS6K), a key substrate of mTOR22, was increased 160 
in PeloepiKO skin, and reduced by rapamycin (Extended Data Fig. 9k). However, rapamycin did 161 
not prevent disruption of hair follicle and sebaceous gland architecture (Extended Data Fig. 9h). 162 
 163 
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Simultaneous rapamycin treatment and Pelo deletion largely prevented Pelo-mediated disruption 164 
of epidermal homeostasis (Fig. 4m, n). TEWL, epidermal thickening and proliferation were 165 
substantially reduced (Fig. 4o-u; Extended Data Fig. 9l); pS6K labeling was reduced (Fig. 4v) 166 
and phosphorylation of another mTOR substrate, 4EBP1, was decreased (Extended Data Fig. 167 
9m). Therefore the epidermal Pelo deletion phenotype is largely attributable to increased protein 168 
translation. 169 
 170 
Our results indicate that translational control is critical for tissue homeostasis3,4,13 and establish a 171 
link between Pelo inactivation and translational activation via mTOR. mTOR is known to 172 
regulate cell growth and proliferation22,24 and is activated upon ribosome-stalling by Fragile X 173 
Mental Retardation Protein25,26. Impaired ribosomal biogenesis also activates mTOR1 signaling 174 
and stimulates translation initiation and elongation factors27. mTOR signaling may be activated 175 
to enhance the efficiency of the translational machinery in order to compensate for impaired or 176 
reduced availability of ribosomes8,28.  177 
 178 
The increased size of Pelo-null epidermal cells as a result of increased protein synthesis23,30 may 179 
stimulate differentiation through decreased basement membrane engagement29 and thus 180 
indirectly promote proliferation. Factors that may account for the selective sensitivity of Lrig1+ 181 
cells to Pelo deletion, include their proliferative state, abundance and location relative to Lgr5+ 182 
and Lgr6+ cells, together with their known ability to repopulate different epidermal 183 
compartments31.  184 
 185 
 186 
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Methods 298 
 299 
Mouse strains 300 
All mouse experiments were performed under a UK Government Home Office project license 301 
and subject to local institutional ethical approval. The generation of conditional Pelofl/fl 302 
(Pelotm1Imad) mice was described elsewhere32. To derive constitutive Pelo epidermal knockout 303 
mice (PeloepiKO), Pelofl/fl mice were crossed with Krt14Cre mice (Jax strain, stock number 304 
004782). To achieve temporally controlled Pelo knockout and genetic labeling of cells lacking 305 
Pelo, Pelofl/fl mice were crossed with Krt14CreERT (Jax strain, stock number 005107), Lrig1EGFP-306 
IRES-CreERT2 mice31, Lgr5EGFP-IRES-CreERT2 mice33, Lgr6EGFP-IRES-CreERT2 mice34 and Rosa26LoxP-Stop-307 
LoxP-tdTomato mice35. To activate Cre recombinase, 4-Hydroxytamoxifen (4-OHT, Sigma-Aldrich) 308 
was dissolved in acetone and applied topically (3 mg/100 μl) every day for five days and once a 309 
week for three weeks. For proliferation assays, 5-ethynyl-2′-deoxyuridine (EdU) (Invitrogen, 20 310 
mg kg-1   body mass; in PBS) was injected intraperitonially and the tissue was harvested 1 hr 311 
later. To derive constitutive Pelo dermal knockout mice (PeloderKO), Pelofl/fl mice was crossed 312 
with Dermo1Cre (B6.129X1-Twist2tm1.1(cre)Dor/J)36,37. Mouse lines used in this study with the 313 
location of expression of markers in the skin are illustrated in the Extended Data Fig. 10k.  314 
Hbs1l-/-  (Hbs1ltm1a(KOMP)Wtsi) mice were produced at the Wellcome Trust Sanger Institute Mouse 315 
Genetics Project as part of International Mouse Phenotype Consortium (IMPC)38.  316 
Library generation for ribosome profiling 317 
Samples of PeloepiKO epidermis for ribosome profiling and RNA-Seq were prepared by scrapping 318 
off the epidermal layer in liquid nitrogen. Frozen samples were ground using a Mixer Mill 319 
(Retch) and thawed in the presence of polysome lysis buffer. Lysates were clarified by 320 
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centrifugation at 20,000g for 10 minutes at 4˚C and the supernatant was collected. Total lysate 321 
RNA was quantified using the Quant-it RNA kit (Thermo) and 5 µg was used for preparation of 322 
ribosome profiling libraries as described previously15. Total RNA was size-selected by excising 323 
gel regions between phosphorylated 16nt and 34nt RNA oligo standards. Ribosomal RNAs were 324 
depleted using Ribo-Zero Gold (Illumina) after footprint size-selection. 100ng was used for 325 
preparation of RNA-Sequencing libraries from the same samples as profiling libraries. Analysis 326 
using a BioAnalyzer total RNA pico chip was used to confirm RNA integrity (RIN >9) for RNA 327 
sequencing samples. The datasets are deposited in GEO under accession number GSE94385. 328 
 329 
Sequencing and data analysis 330 
Ribosome profiling and RNA-Seq libraries were sequenced using a HiSeq2500 (Illumina). ~110 331 
million total raw reads were generated from 4 ribosome profiling samples with between 11 and 332 
30 million reads mapping to the genome per sample. For ribosome profiling analysis, only 333 
singly-mapped reads (NH:i:1) with no mismatches (NM:I:0) were used. Translational efficiency 334 
(TE) was calculated as number of CDS RPFs / RPKM. Relative 3´UTR ribosome occupancy was 335 
calculated as 3´UTR footprint density / CDS footprint density. For differential gene expression 336 
analysis, we uploaded the list of differentially expressed genes into Ingenuity IPA and ran a core 337 
analysis. This identified the top molecules, pathways and master regulators that are different 338 
between control and PeloepiKO samples. 339 
 340 
Polysome analysis 341 
Epidermal layers from WT and Pelo epiKO were lyzed as described above (see Library generation 342 
for ribosome profiling). Clarified lysates were loaded on 10-50% sucrose gradients prepared in 343 
polysome gradient buffer (20mM Tris-HCl [pH8], 150mM KCl, 5mM MgCl2, 0.5mM DTT, 344 
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0.1mg/mL cycloheximide), and gradients were spun in an SW41-Ti rotor at 40,000 rpm for 3 hr 345 
at 4°C. Gradients were fractionated using a Brandel Density Gradient Fractionation System. 346 
Prior to RNA extraction, CLuc mRNA (NEB) was added in each fraction. RNA was extracted 347 
using hot acidic phenol and cDNA was synthesized using iScript cDNA synthesis kit (Bio-Rad) 348 
according to manufacturer’s instructions. qPCR was carried out using iTaq Universal SYBR 349 
Green Supermix (Bio-Rad). Relative mRNA abundances in indicated fractions were normalized 350 
to CLuc mRNA to account for differences in RNA extraction efficiency among fractions, and 351 
then calculated as fold changes normalized to 80S fractions. qPCR primers:  CLuc Forward 5 ́-352 
GCTTCAACATCACCGTCATTG-3’, CLuc Reverse 5’-CACAGAGGCCAGAGATCATTC-3 ́, 353 
Krt86 Forward 5’-AACAGAATGATCCAGAGGCTG–3’, Krt86 Reverse 5’- 354 
GCTCAGATTGGGTCACGG-3’. 355 
 356 
RNA-seq library preparation and analysis 357 
Primary epidermal cell suspension was prepared as previously described39. Briefly, cells were 358 
harvested from 3 months old 4-OHT treated Pelofl/+; Lrig1EGFP-CreERT2, Pelofl/+; Lgr5EGFP-CreERT2, 359 
Pelofl/+; Lgr6EGFP-CreERT2 control mice and Pelofl/fl; Lrig1EGFP-CreERT2, Pelofl/fl; Lgr5EGFP-CreERT2, 360 
Pelofl/fl; Lgr6EGFP-CreERT2 Pelo mut mice. Total epidermal population was FACS sorted for GFP+ 361 
cells on a BD FACSAriaII cell Sorter and 1000 GFP-high cells collected from each population 362 
for RNA-seq. Library construction and the strategy for RNA-seq was performed using Smart-363 
seq2 method as reported previously40. Fastq files of paired-end reads were uploaded to Galaxy 364 
platform41 and aligned using STAR aligner42 to Mus musculus reference genome 365 
(GRCm38/Mm10). BAM files were processed in R using “rnaseqGene” workflow43. The data 366 
were analysed using the edgeR package. Processed data were mined using IPA Ingenuity 367 
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Pathway Analysis (Qiagen). The datasets are deposited in GEO under accession number 368 
GSE106246. 369 
 370 
Flow cytometry for measurement of cell size, cycle and protein synthesis in vivo 371 
To analyse cell size by flow cytometry, epidermal cells were isolated as previously described39. 372 
Briefly, epidermis was enzymatically separated from dermis with thermolysin (Sigma, 0.25 373 
mg/mL in PBS) overnight at 4°C. Epidermal sheets were processed into single cell suspensions 374 
by incubation in DMEM (Gibco) containing DNAse (Sigma, 250 µg/mL) for 20 min at 37°C 375 
with shaking. Single cells were labelled according to standard procedures with anti- Integrin α6-376 
Alexa Fluor 647 or FITC (AbSource, 1:20) antibody. To assess the percentage of proliferating 377 
epidermal cells, mice were injected with 500µg 5-ethynyl-2’-deoxyuridine (EdU; 2.5mg/mL in 378 
PBS) intraperitoneally and back skin was harvested 2 hr later. Cells were isolated as described 379 
above and single cell suspensions were stained with the Click-iT EdU Alexa Fluor 488 Flow 380 
Cytometry Kit (Invitrogen) according to the manufacturer’s suggestions. Cell cycle analysis was 381 
performed on a BD LSR Fortessa cell analyser. Proliferating cells that had incorporated EdU 382 
were detected in the FITC/Alexa Fluor 488 channel. 383 
 384 
To measure protein synthesis in vivo, mice received an intraperitoneal injection of O-propargyl-385 
puromycin (OP-P) (Medchem Source or Thermo Fisher (C10459); 50 mg kg-1 body mass; pH 386 
6.4–6.6 in PBS). One hour later mice were euthanized and back and tail skin samples were 387 
collected. Epidermal dissociation was performed as described above. The staining for detection 388 
of protein synthesis was performed according to the manufacturer instructions (Click-iT Plus 389 
OPP Protein Synthesis Assay Kit; Thermofisher Scientific). Samples from PBS-injected mice 390 
were also stained for detection of protein synthesis and the fluorescence signal was used to 391 
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determine background labelling. Rates of protein synthesis were calculated as described 392 
previously3. Briefly, OP-P signals were normalized to whole epidermis after subtracting 393 
autofluorescence background. ‘Mean OP-Puro fluorescence’ reflected fluorescence values for 394 
each cell population normalized to whole epidermis. Labelled cells were analysed on a BD 395 
LSRFortessa cell analyser. All data were analysed using FlowJo software.  396 
 397 
Histology, epidermal wholemounts and imaging 398 
For paraffin sections, skin samples were fixed with 10% neutral buffered formalin overnight 399 
before paraffin embedding. The tissues were sectioned and stained with haematoxylin and eosin 400 
(H&E) and Herovici’s stain by conventional methods. For frozen sections, skin samples were 401 
embedded on OCT (optimal cutting temperature compound; VWR), sectioned and fixed in 4% 402 
PFA for 10 min before staining. Slides were mounted using ProLong Gold anti-fade reagent 403 
containing DAPI (Life Technologies) as a nuclear counterstain. Images were acquired using a 404 
Hamamatsu slide scanner and analysed using NanoZoomer software (Hamamatsu). 405 
The epidermal wholemount labelling procedure was performed as described previously44,45. In 406 
brief, mouse tail was slit on the ventral side lengthways. Pieces (0.5x0.5 cm2) of skin were 407 
incubated in 5 mM EDTA in PBS at 37 °C for 4 h. Epidermis was gently peeled from dermis as 408 
an intact sheet in a proximal to distal direction, corresponding to the orientation of the hairs, and 409 
then the epidermis was fixed in 4% paraformaldehyde (PFA; Sigma) for 1 h at room temperature. 410 
Fixed epidermal sheets were washed in PBS and stored in PBS containing 0.2% sodium azide at 411 
4° C.  412 
Confocal image acquisition of stained wholemounts and skin sections were performed using a 413 
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Nikon A1 confocal microscope. Images were analysed using NIS Elements (Nikon Instruments 414 
Inc.). Photoshop CS5 (Adobe image suite) was used to optimize the images globally for 415 
brightness, contrast and colour balance.  416 
Rapamycin treatment 417 
Rapamycin (LC Laboratories, R5000) was dissolved in acetone. Rapamycin treatment groups 418 
received topical applications of 500 μl 0.2% Rapamycin on dorsal and tail skin. Vehicle 419 
treatment group mice received an equal volume of acetone without rapamycin. Dorsal skin was 420 
shaved before the day of treatment. 421 
 422 
Wound and TEWL assays  423 
Full-thickness wounds were made on the lower dorsal skin (5mm) or tail (2mm) using punch 424 
biopsy (Stiefel) under analgesia and general anaesthesia. The hair on the back was shaved prior 425 
to wounding. Wound closure was measured using a Vernier scale. Epidermal barrier function 426 
was assessed by testing basal transepidermal water loss (TEWL) on the dorsal skin of mice using 427 
a TEWAmeter (Courage and Khazaka, TM210). Measurements were collected for 15–20 428 
seconds when TEWL readings had stabilized, at approximately 30 seconds after the probe collar 429 
was placed on the dorsal skin. 430 
 431 
Antibodies 432 
Primary antibodies for wholemount and tissue sections were: chicken anti-Krt14 (Covance, 433 
SIG2376, 1:500) or directly conjugated (AlexaFluor 555) Krt14 (LL002, in house, 1:200); 434 
directly conjugated (AlexaFluor 488) Krt15 (LHK-15, in-house, 1:50); human anti-p63 (SCBT, 435 
sc367333, 1:100); rabbit anti-filaggrin (Covance, PRB-417P, 1:100); mouse anti-FASN (SCBT, 436 
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sc48357, 1:100); rabbit anti-Ki67 (Novocastra, NCL-Ki67p, 1:500); rabbit anti-Ki67 (abcam, 437 
ab16667, 1:500); rabbit anti- Phospho-S6 Ribosomal Protein (Ser235/236)  (pS6K, Cell 438 
signaling, 2211, 1:200); rabbit anti-P-Cadherin (Cell signaling, 2130, 1:200); rabbit anti-439 
Vimentin (Cell signaling, 5741s, 1:500); rabbit anti-K10 (Covance, PRB-159P, 1:500); FITC 440 
conjugated rat anti-CD49f (Integrin 6, Biolegend, 313606, 1:100); goat anti-Lrig1 (R&D 441 
Systems, FAB3688G, 1:200); rabbit anti-Scd1 (Cell signaling, 2794s, 1:500); mouse anti-442 
involucrin (SY5, in-house, 1:500); mouse anti-Pankeratin (abcam, ab8068, 1:200); rat anti-CD34 443 
(RAM34, Thermo Fisher, 14-0341-82, 1:200); Rabbit anti-Phospho-4EBP1 (Thr37/46) (Cell 444 
Signalling, 236B4, 1:500) AlexaFluor (Life Technologies) dye-conjugated secondary antibodies 445 
were used at 1:250 dilutions.  446 
 447 
In vitro knockdown, clonogenicity and skin reconstitution assay 448 
Primary human keratinocytes (strain km) were isolated from neonatal foreskin and cultured on 449 
mitotically inactivated 3T3-J2 feeder cells in complete FAD medium, containing 1 part Ham's 450 
F12 medium and three parts Dulbecco's modified Eagle’s medium (DMEM), 10-4 M adenine, 451 
10% (v/v) FBS, 0.5 μg ml-1 hydrocortisone, 5 μg ml-1 insulin, 10-1 M cholera toxin and 10 ng 452 
ml-1 EGF, as described previously46,47. siRNA mediated gene silencing was performed as 453 
described previously48. Briefly, keratinocytes were transferred to feeder free conditions in 454 
keratinocyte serum-free medium (KSFM) containing 30 μg ml−1 BPE (bovine pituitary extract) 455 
and 0.2 ng ml−1 EGF (Gibco) for 2–3 days. Cells were trypsinized at ~70% confluence and 456 
resuspended in cell line buffer SF (Lonza). For each 20μl transfection (program FF-113), 2×105 457 
cells were mixed with 1–2μM siRNA duplexes (Silencer select siRNA for PELO ID131910, 458 
ID131911, ID131912, as well as negative control, Ambion). Transfected cells were incubated at 459 
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room temperature for 5–10 min and subsequently resuspended in pre-warmed KSFM. siRNA 460 
nucleofections were performed with the Amaxa 16-well shuttle system (Lonza). Alternatively, 461 
keratinocytes cells were transfected by using INTERFERin (Polyplus transfections): 36pmol 462 
siRNA, 4ul INTERFERin reagent, and 200ul KSFM were mixed in the collagen coated (20ug/ml 463 
in PBS, 1h, 37°) 12-well plate and incubated 20min at room temperature. After the incubation, 464 
75, 000 keratinocytes were seeded to the well (final concentration of siRNA 30nM). Medium 465 
was changed after 4 hrs and cells were harvested after 48 hrs.  466 
 467 
For clonogenicity assays, nucleofected keratinocytes were seeded at low density (100-250 cells 468 
per well) on a prepared feeder layer in 6-well plates containing FAD medium. Keratinocytes 469 
were maintained in culture for 12 days and then feeders were removed by Versene treatment 470 
combined with tapping the culture flask. Once all the feeder cells were washed away, the 471 
remaining keratinocytes colonies were fixed with 4% PFA at room temperature for 10 min. 472 
Colonies were then stained with 1% Rhodanile Blue (1:1 mixture of Rhodamine B and Nile Blue 473 
A (Acros Organics) solution for 15min and washed with distilled water prior to examination. 474 
Stained dishes containing keratinocyte colonies were imaged using a Molecular Imager Gel Doc 475 
XR+ imaging system (Bio-Rad). Colonies were measured using ImageJ and clonogenicity was 476 
calculated as the percentage of plated cells that formed colonies. 477 
 478 
For the skin reconstitution assay, pre-confluent keratinocyte cultures (KM passage 3) were 479 
disaggregated and transfected either with PELO siRNAs or scrambled control siRNAs. 24 hours 480 
post-transfection, keratinocytes were collected and reseeded on irradiated de-epidermised human 481 
dermis in 6-well Transwell plates with feeders and cultured at the air–liquid interface for three 482 
  20
weeks49. Organotypic cultures were fixed in 10% neutral buffered formalin (overnight), paraffin 483 
embedded and sectioned for H&E and immunofluorescence analysis.  484 
 485 
Picrosirius birefringence and dermal thickness and cell density  486 
12µm paraffin sections were stained with picrosirius red using a standard method50. Briefly, the 487 
sections were de-paraffinized, washed twice with water and stained 1 hr in picrosirius red 488 
solution (0.1% Sirius red F3B in saturated aqueous solution of picric acid). After the staining, 489 
sections were washed twice with acidified water (0.5 % acetic acid), dehydrated, cleared with 490 
xylene, and mounted with DPX mounting medium. The images were acquired using Zeiss 491 
Axiophot microscope and AxioCam HRc camera under plane-polarized light. The quantification 492 
of total collagen fibers was performed by Fiji (ImageJ) software. The collagen pixels were 493 
selected by Color Treshold tool (Hue 0-100, Saturation 0-255 and Brightness 230-255).  494 
Thickness of dermis was quantified by NanoZoomer Digital Pathology software (Hamamatsu). 495 
The number of cells was determined with ImageJ by counting the nucleus in DAPI stained tissue 496 
sections.  497 
 498 
Statistics 499 
Statistical significance in all experiments was calculated by Student’s t test. Data are represented 500 
as mean ±SEM (error bars). GraphPad Prism was used for calculation and illustration of graphs. 501 
 502 
Data Availability 503 
All experimental data generated during/and or analysed this study are included in this published 504 
article (and its supplementary information files). In addition, ribosome profiling data (accession 505 
number GSE94385) and RNAseq data (accession number GSE106246) are available in GEO. 506 
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each GO category are presented in separate tabs. 562 
Table S3: GO analysis of differentially expressed transcripts.  Genes enriched for each GO 563 
category are presented in separate tabs. 564 
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populations. 568 
Table S5: List of upstream regulators and canonical pathways activated in among and between 569 
control Lrig1+, Lgr5+ and Lgr6+ subpopulations. 570 
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Fig. 1. Differential effects of Pelo deletion PeloderKO (a-f) and PeloepiKO (g-u) mice. (h) 
Arrows: skin abnormalities. (c, d, l, m) H&E staining of back (c, d) and tail (l, m) skin. 
Dermal cellularity (d) and epidermal thickness (m) were measured. n=2-4 sections from n=3 
mice. (e, f, n, p-r) Immunolabelling of sections (e, f, n, p) and wholemounts (q, r). Asterisks: 
non-specific; arrow: suprabasal labelling; dashed lines: epidermal-dermal boundary. (m, n) 
***p<0.001, n=3 mice. (i) Kaplan-Meier curves (n=29 mice). (j) Body weight: ***p<0.0003; 
n=5 per group. (k) TEWL. p<0.05; n=3. (s) Quantification of proliferation. **p=0.0086; 
***p=0.0003 for Ki67; 0.0006 for EdU; n=3. (t) Cumulative mean values of gene expression 
from ribosome profiling. (u) Wound closure. *p=0.0500; n=3. Ctrl: littermate controls. Scale 
bars 100 µm. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Fig. 2. Lrig1+ stem cells account for Pelo mutant epidermal phenotype (a-c) Schematics 
of Lrig1, Lgr5 and Lgr6 expression (a), breeding (b) and 4-OHT treatment (c). (d, e) 
Immunostaining of dorsal skin IFE sections (d) and tail wholemounts (e) with antibodies to 
the markers shown. (e) Asterisk: altered SG; arrow: altered JZ. (g-i) Quantification of 
proliferation (f), epidermal thickness (g) and TEWL (h). IFE, interfollicular epidermis; Inf, 
infundibulum; SG, sebaceous gland; JZ junctional zone; Bu, bulge; HG, hair germ. Scale bars 
50 µm (d, f); 100 µm (e). Dashed lines: epidermal-dermal boundary. ***p=0.0010 (g, p63); 
***p=0.0005; *p=0.0330, **p = 0.0071 (g, Ki67); **p=0.0083 (g, EdU). **p=0.0044, 0.0011 
(h). *p=0.0167 (i), n = 3 to 5 mice per group. n.s., non significant.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Fig. 3. Accumulation of short ribosome footprints and global translational changes in 
Pelo knockout epidermis (a) Metagene analysis of full length and short RPFs near the start 
(left) and stop (right) codons. (b) RPF read length distributions. (c) Empiric cumulative 
distribution plot of global enrichment of short 20-21nt relative to expected 28-34nt reads. (d) 
Designations of -15 peaks indicate positions of 5´ end of RPF; corresponding P site 
occupancy shown. (e) Relative enrichment of short RPFs (y-axis) and change in RNA 
transcript levels (x-axis). (f) Replicate analysis of translational efficiency (TE). (g) MA plot 
showing observed and expected variance in TE measurements; p-adjusted <0.01, blue 
transcripts. (h) Canonical pathways linked to translation regulation in PeloepiKO. (i) Epidermal 
polysome profiling. (j) qRT-PCR shows significant increase in heavy polysome bound Krt86 
mRNA; p=0.019.  
 
 
 
 
 
 
 
 
 
 
 
 
 

Fig. 4. Inhibition of mTOR pathway attenuates Pelo phenotype progression (a-d, r, t, v) 
Immunolabelling for markers indicated. (s, u) Quantitation: **p=0.0064 (s); ***p=0.0006 (u). 
(b-l) OP-Puro injected newborn (b-j) and adult (k, l) mice. (e-k) Representative flow 
histograms and (i, j, l) quantitation; n=3 mice per group. *p=0.0406 (i), 0.0357 (j), 0.0198 (l). 
(m-v) 4-OHT and rapamycin (Rapa) treatment. (o) TEWL; *p=0.0145. (p, q) H&E stained 
dorsal skin. *p=0.0286. Scale bars 50 µm (a); 100 µm (b-d; p, r, s, v), n = 3-4 mice per group.  
 
